Vera Hernandez Holmes, PA
Medical · Milford, MANPI 1023299864
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,578 of the $5,008 with a category attached, or 71.5%. 16 manufacturers reported payments, led by Medtronic at 25.4% of the total. Reporting peaked in 2022 at $2,136 and has fallen 98.7% since, to $28 in 2025. Among medical clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $25.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$810
- Braintree Laboratories, Inc.$285
- Ferring Pharmaceuticals Inc.$275
- Bristol Myers Squibb$260
- plus $930 from 10 others
What the payments were for
- Consulting fees$1,18024%
- Travel & lodging$942%
- Food & beverage$3,57871%
- Education$1142%
- Gifts$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $1,274 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 58 | $1,174 |
| AbbVie | 42 | $810 |
| Braintree Laboratories, Inc. | 29 | $285 |
| Ferring Pharmaceuticals Inc. | 10 | $275 |
| Bristol Myers Squibb | 13 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $237 |
| Johnson & Johnson | 9 | $209 |
| Medical Device Business Services, Inc. | 1 | $98 |
| Pfizer | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Daiichi Sankyo Inc. | 4 | $73 |
| Alnylam Pharmaceuticals Inc. | 3 | $70 |
| Gilead | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $18 |
How this compares
$5,008 in reported general payments places this provider in the 95th percentile of 421 medical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 36 | $47 |
Paid to pharmacies, not to this prescriber.
Other medical in Milford
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.